Evaluation of the eAdjust Application

February 18, 2020 updated by: Nottingham University Hospitals NHS Trust

Evaluation of the eAdjust Application to Provide Benefits in Users of Smartphone-connected Hearing Aids

Despite being effective, the majority of people who would benefit from using hearing aids do not access them. For those who do obtain hearing aids, around 20% do not wear them regularly. People often do not use their hearing aids because they continue to experience difficulties when listening to and understanding speech in noisy situations.

Conventional hearing aids must be programmed and adjusted by a trained audiologist with specialist equipment and therefore provide limited user-control over the hearing aid's functionality. In comparison to conventional hearing aids, Smartphone-connected hearing aids enable patients to adjust their programmes themselves in different situations using a Smartphone application. Smartphone-connectivity can supplement clinical practices, as patients can adjust their hearing aids without the need to visit the clinic. This has the potential to empower patients to be actively involved in their own hearing healthcare.

A systematic review assessing the effectiveness of alternative listening devices showed that there is no published high-quality research assessing the clinical effectiveness of Smartphone-connected hearing aids. Furthermore, a usability research study has shown that patients want to personalise and adjust their own HA programmes to meet their individual needs. Having carried out the early development work, the next step would be to carry out a study to evaluate smartphone-connected hearing aids, in accordance with the MRC guidelines on developing and evaluating complex interventions.

This study will assess the benefits of a smartphone application, eAdjust that has been developed for use with Phonak Audeo B90-Direct hearing aids. The eAdjust app connects to the hearing aid via Bluetooth, and enables hearing aid users to fine-tune their hearing aids via their smartphone. The benefits of the eAdjust app will be assessed in the real-world as well as in the laboratory. A mixed methods approach will be taken, using both behavioural and patient reported outcomes.

Study Overview

Study Type

Observational

Enrollment (Actual)

46

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Non-US/Non-Canadian
      • Nottingham, Non-US/Non-Canadian, United Kingdom, NG1 5DU
        • National Institute for Health Research Nottingham Biomedical Research Centre

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Hearing aid users (first-time and existing) will be recruited from Nottingham Audiology Adult Service, Nottingham University Hospitals NHS Trust (secondary care). Immediately following the patient's hearing assessment appointment, a member of the patient's usual care team (audiologist) will identify eligible patients.

Description

Inclusion Criteria:

  • Adults aged ≥18 years.
  • With hearing loss type: symmetric (not more than 20 dB difference) and sensorineural.
  • With mild to severe hearing loss in the categories: N2, N3, N4, N5, S2 and S3.
  • No disturbing tinnitus.
  • No contraindications against wearing hearing aids (e.g. ear disease or motor impairment).
  • Hearing aid user:

    1. First-time (using hearing aids < 3 months)
    2. Existing (using hearing aids > 6 months)
  • Owns an iPhone (v5 and IOS 10 or higher) and uses functions of her/his smartphone which exceed calling and writing text messages.
  • Willing to wear test hearing aids, to use the eAdjust App, to take notes about experiences and to perform various tasks during the study period.
  • English as a first spoken language or a good understanding of English. It is important that participants can understand the content of the resources and work with the interactive elements, as well as be able to answer outcome questionnaires, to ensure valid data are collected.

Exclusion Criteria:

- Unable to complete the questionnaires without assistance due to age-related problems (e.g. cognitive decline or dementia), to ensure valid data are collected.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
First-time hearing aid user
Using hearing aids less than or equal to three months.
The app connects to the Audeo B-90 Direct hearing aids via Bluetooth. The intended use for the app to enable hearing aid users to fine-tune their hearing aids. The app contains a series of sound modifiers, factory presets, sound modifier presets.
Existing hearing aid user
Using hearing aids for 6 months or more.
The app connects to the Audeo B-90 Direct hearing aids via Bluetooth. The intended use for the app to enable hearing aid users to fine-tune their hearing aids. The app contains a series of sound modifiers, factory presets, sound modifier presets.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Hearing Handicap Inventory for the Elderly
Time Frame: Change from Baseline following 7-weeks of intervention use.
25-item self-reported questionnaire assessing the effects of hearing loss on the emotional and social/situational adjustment. Scored using a three-point scale.
Change from Baseline following 7-weeks of intervention use.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Glasgow Hearing Aid Benefit Profile
Time Frame: Baseline (Part I) and following 7-weeks of intervention use (Part II).
Assesses self-reported hearing disability and handicap (Part I), as well as hearing aid use, benefit, residual disability and satisfaction (Part II). Each domain is measured on a five-point scale.
Baseline (Part I) and following 7-weeks of intervention use (Part II).
Vanderbilt Fatigue Scale for Adults with Hearing Loss
Time Frame: Change from Baseline following 7-weeks of intervention use.
A 40-item self-report measure of listening effort and fatigue. Scored using a five-point scale.
Change from Baseline following 7-weeks of intervention use.
Device-Orientated Subjective Outcome scale
Time Frame: Change from Baseline following 7-weeks of intervention use.
Self-report questionnaire suitable for quantifying subjective hearing aid outcomes. Scored using a seven-point response scale.
Change from Baseline following 7-weeks of intervention use.
Glasgow Hearing Aid Difference Profile (existing hearing aid users only)
Time Frame: Change from Baseline following 7-weeks of intervention use.
Assesses self-reported use and residual disability with 'old' hearing aids (Part I), as well as use and residual disability with 'new' hearing aids, and the difference in benefit and and satisfaction between 'old and 'new' hearing aids (Part II). Each domain is measured on a five-point scale.
Change from Baseline following 7-weeks of intervention use.
Auditory Lifestyle and Demands Questionnaire
Time Frame: Following 1-week of intervention use.
Self-report measure of auditory lifestyle.
Following 1-week of intervention use.
Clarity and Comfort Questionnaire
Time Frame: Following 1-week of intervention use.
Self-report measure of hearing aid preferences concerning sound clarity and comfort.
Following 1-week of intervention use.
Hearing aid datalogging
Time Frame: Following 1-week and 7-weeks of intervention use.
Hearing aid use in hours, internal to the hearing aid.
Following 1-week and 7-weeks of intervention use.
Montreal Cognitive Assessment
Time Frame: Following 1-week of intervention use.
Validated screening tool for mild cognitive impairment.
Following 1-week of intervention use.
BKB Speeh-In-Noise Test
Time Frame: Following 1-week and 7-weeks of intervention use.
Behavioural measure of speech intelligibility in the presence of background noise.
Following 1-week and 7-weeks of intervention use.
eAdjust 0.2 app datalogging
Time Frame: Following 2-week and 6-weeks of intervention use.
Usage data, internal to the app.
Following 2-week and 6-weeks of intervention use.
App real-world use questionnaire
Time Frame: Following 2-week and 6-weeks of intervention use.
Self-report questionnaire of app usage. Consists of closed- and open-ended questions.
Following 2-week and 6-weeks of intervention use.
Hearing aid tasks
Time Frame: Following 2-week and 6-weeks of intervention use.
Self-report questionnaire of app functionality in different environments.
Following 2-week and 6-weeks of intervention use.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

August 23, 2018

Primary Completion (ACTUAL)

December 14, 2018

Study Completion (ACTUAL)

April 30, 2019

Study Registration Dates

First Submitted

September 13, 2018

First Submitted That Met QC Criteria

September 14, 2018

First Posted (ACTUAL)

September 17, 2018

Study Record Updates

Last Update Posted (ACTUAL)

February 19, 2020

Last Update Submitted That Met QC Criteria

February 18, 2020

Last Verified

March 1, 2019

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hearing Loss, Sensorineural

3
Subscribe